SCHEMBL20093469

SCHEMBL20093469

Cc1ccc(N(C)CCN(C)c2cccc(C)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 1/20 0.47
▸ ICMT O60725 1/20 0.42
▸ HSD17B1 P14061 4/20 0.42
▸ HSD17B2 P37059 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ PAX8 Q06710 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ GPX4 P36969 1/20 0.40
▸ NOS1 P29475 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NSD2 O96028 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11138993 0.92 HTR7 (0.51) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL11139614 0.84 HTR7 (0.56) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL17084932 0.82 HTR7 (0.48) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL14612439 0.81 HTR7 (0.45) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL14287627 0.81 NOS1 (0.52) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL8095675 0.81 HTR7 (0.47) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL10980020 0.81 HTR7 (0.47) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL22537868 0.81 HTR7 (0.47) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL13475062 0.79 ACHE (0.48) HTR7ICMTHSD17B1HSD17B2ALDH1A1
SCHEMBL11317252 0.79 HTR7 (0.52) HTR7ICMTALDH1A1ACHENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 — — US disclosed
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2019-04-11 — — US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190105324-A9 SUBSTITUTED CHROMENONES AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKAR2B HTR7 1816/4885ICMT 4826/4885HSD17B1 1227/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB HTR7 3479/4885ICMT 4737/4885HSD17B1 3516/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 HTR7 1836/4885ICMT 4600/4885HSD17B1 1066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback